T. Rowe Price Investment Management, Inc. Zoetis Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 46,044 shares of ZTS stock, worth $8.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,044
Previous 25,845
78.15%
Holding current value
$8.02 Million
Previous $5.1 Million
52.72%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ZTS
# of Institutions
1,862Shares Held
416MCall Options Held
1.13MPut Options Held
1.81M-
Vanguard Group Inc Valley Forge, PA40.7MShares$7.1 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY36.7MShares$6.4 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$3.41 Billion0.15% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16.2MShares$2.81 Billion2.46% of portfolio
-
Bank Of America Corp Charlotte, NC14MShares$2.43 Billion0.22% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $81.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...